prof. dr. Pieter Depuydt

Journal Article
A1
open access

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge

Natalie Lorent, Yannick Vande Weygaerde (UGent) , Eveline Claeys, Ipek Guler Caamano Fajardo, Nicolas De Vos, Walter De Wever, Bihiyga Salhi (UGent) , Iwein Gyselinck, Cedric Bosteels (UGent) , Bart Lambrecht (UGent) , et al.

(2022) ERJ OPEN RESEARCH. 8(2).

Add to list

Healthcare-associated infections in adult intensive care unit patients : changes in epidemiology, diagnosis, prevention and contributions of new technologies

Stijn Blot (UGent) , Etienne Ruppé, Stephan Harbarth, Karim Asehnoune, Garyphalia Poulakou, Charles-Edouard Luyt, Jordi Rello, Michael Klompas, Pieter Depuydt (UGent) , Christian Eckmann, et al.

(2022) INTENSIVE AND CRITICAL CARE NURSING.

Add to list

Antimicrobial prescription in severe COVID-19 and CAP : a matched case-control study

Jan Fierens (UGent) , Liesbet De Bus (UGent) , Kirsten Colpaert (UGent) , Jerina Boelens (UGent) , Bram Gadeyne (UGent) , Johan Decruyenaere (UGent) , Eva Van Braeckel (UGent) and Pieter Depuydt (UGent)

(2022) ACTA CLINICA BELGICA.

Add to list

Foxglove poisoning : diagnostic and therapeutic differences with medicinal digitalis glycosides overdose

Koen Maes, Pieter Depuydt (UGent) , Joris Vermassen (UGent) , Peter De Paepe (UGent) , Walter Buylaert (UGent) and Cathelijne Lyphout (UGent)

(2022) ACTA CLINICA BELGICA. 77(1). p.101-107

Add to list

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Jozefien Declercq (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes (UGent) , Cedric Bosteels (UGent) , Simon Tavernier, Stefanie De Buyser (UGent) , Roos Colman (UGent) , Maya Hites, Gil Verschelden, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(12). p.1427-1438

Add to list

Journal Article
A1
open access

Characteristics of Sepsis-2 septic shock patients failing to satisfy the Sepsis-3 septic shock definition : an analysis of real-time collected data

Joris Vermassen (UGent) , Johan Decruyenaere (UGent) , Liesbet De Bus (UGent) , Pieter Depuydt (UGent) and Kirsten Colpaert (UGent)

(2021) ANNALS OF INTENSIVE CARE. 11(1).

Add to list

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Jozefien Declercq (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes (UGent) , Cedric Bosteels (UGent) , Simon Tavernier (UGent) , Stefanie De Buyser (UGent) , Roos Colman (UGent) , Maya Hites, Gil Verschelden, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(12). p.1427-1438

Add to list

Journal Article
A1
open access

Outcomes of ICU patients with and without perceptions of excessive care : a comparison between cancer and non-cancer patients

Dominique Benoit (UGent) , Esther N. van der Zee, Michael Darmon, An K. L. Reyners, Victoria Metaxa, Djamel Mokart, Alexander Wilmer, Pieter Depuydt (UGent) , Andreas Hvarfner, Katerina Rusinova, et al.

(2021) ANNALS OF INTENSIVE CARE. 11(1).

Add to list

Journal Article
A1
open access

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Paul E. Verweij, Roger J. M. Brüggemann, Elie Azoulay, Matteo Bassetti, Stijn Blot (UGent) , Jochem B. Buil, Thierry Calandra, Tom Chiller, Cornelius J. Clancy, Oliver A. Cornely, et al.

(2021) INTENSIVE CARE MEDICINE. 47(8). p.819-834

Add to list

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial

Lore Vanderbeke, Nico A. F. Janssen, Dennis C. J. J. Bergmans, Marc Bourgeois, Jochem B. Buil, Yves Debaveye, Pieter Depuydt (UGent) , Simon Feys, Greet Hermans, Oscar Hoiting, et al.

(2021) INTENSIVE CARE MEDICINE. 47(6). p.674-686

Academic Bibliography

prof. dr. Pieter Depuydt

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge

Healthcare-associated infections in adult intensive care unit patients : changes in epidemiology, diagnosis, prevention and contributions of new technologies

Antimicrobial prescription in severe COVID-19 and CAP : a matched case-control study

Foxglove poisoning : diagnostic and therapeutic differences with medicinal digitalis glycosides overdose

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Characteristics of Sepsis-2 septic shock patients failing to satisfy the Sepsis-3 septic shock definition : an analysis of real-time collected data

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Outcomes of ICU patients with and without perceptions of excessive care : a comparison between cancer and non-cancer patients

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial

Contents

Support

Contact